AI Analysis AI Analysis of PRPH AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add PRPH to Watchlist?
  • Easy Tracking In The Watchlist
PDF

ProPhase Labs stock price down 0% on Thursday
(Updated on Jun 11, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jun 04, 2026 Loss -23.23%

No changes to the price of ProPhase Labs stock on the last trading day (Thursday, 11th Jun 2026). During the last trading day the stock fluctuated 0% from a day low at $0.0998 to a day high of $0.0998. The price has fallen in 5 of the last 10 days but is still up by 16.59% over the past 2 weeks.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 10.22% during the next 3 months and, with a 90% probability hold a price between $0.0931 and $0.176 at the end of this 3-month period.

PRPH Signals & Forecast

There are mixed signals in the stock today. The ProPhase Labs stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.111 and $0.112. A break-up above any of these levels will issue buy signals. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Wednesday, June 10, 2026, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for ProPhase Labs stock

ProPhase Labs finds support from accumulated volume at $0.0960 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 7.67%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PRPH) For The Upcoming Trading Day Of Friday 12th

For the upcoming trading day on Friday, 12th we expect ProPhase Labs to open at $0.0998, and during the day (based on 14 day Average True Range), to move between $0.0897 and $0.110, which gives a possible trading interval of +/-$0.0201 (+/-22.42%) up or down from last closing price. If ProPhase Labs takes out the full calculated possible swing range there will be an estimated 22.42% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.100 (0.20%) than the support at $0.0960 (3.81%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is ProPhase Labs stock A Buy?

ProPhase Labs holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.539 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 12, 2026 - $0.0998 ( 0%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

PRPH Performance

Trading levels for PRPH

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.0998 -
R2 0.0998 -
R1 0.0998 -
Price 0.0998
S1 0.0998 -
S2 0.0998 -
S3 0.0998 -

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.120 20.24%
R2 0.103 2.76%
R1 0.100 0.200%
Price 0.0998
S1 0.0960 -3.81%
S2 0.0900 -9.82%
S3 0.0842 -15.63%

PRPH Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 May 13, 2022 May 24, 2022 Jun 03, 2022 $0.300 6.10%
2 Feb 16, 2022 Feb 28, 2022 Mar 10, 2022 $0.300 9.09%
3 May 13, 2021 May 24, 2021 Jun 03, 2021 $0.300 12.05%
4 Nov 20, 2019 Dec 02, 2019 Dec 12, 2019 $0.250 5.92%
5 Dec 26, 2018 Jan 09, 2019 Jan 24, 2019 $0.250 4.13%

FAQ

What is the symbol for ProPhase Labs Stock and on which exchange is it traded?
The symbol for ProPhase Labs is PRPH and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell ProPhase Labs Stock?
ProPhase Labs holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy ProPhase Labs Stock?
ProPhase Labs Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ProPhase Labs Stock.

What's the current price of ProPhase Labs Stock?
As of the end of day on the Jun 11, 2026, the price of an ProPhase Labs (PRPH) share was $0.0998.

What is the 52-week high and low for ProPhase Labs Stock?
The 52-week high for ProPhase Labs Stock is $1.15 and the 52-week low is $0.0680.

What is the market capitalization of ProPhase Labs Stock?
As of the Jun 11, 2026, the market capitalization of ProPhase Labs is 472.753K.
Click to get the best stock tips daily for free!
ABOUT PROPHASE LABS
ProPhase Labs
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. The company also prov...
GOLDEN STAR
Ticker Change Signal Date
EAT
$140.46
13.01% Jun 05
TPR
$140.47
3.50% Jun 04
GLBE
$31.61
5.09% May 05
FIZZ
$34.11
8.36% May 01
W
WCLD
$27.34
12.18% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE